SCAI Expert Consensus Statement on Evaluation, Management, and Special Considerations of Cardio‐Oncology Patients in the Cardiac Catheterization Laboratory | SCAI
Clinical Documents Consensus Statement Icon

SCAI Expert Consensus Statement on Evaluation, Management, and Special Considerations of Cardio‐Oncology Patients in the Cardiac Catheterization Laboratory

Consensus Statement

Endorsed by the Cardiological Society of India and Sociedad Latino Americana de Cardiologıa Intervencionista (SOLACI)

Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure. This document provides recommendations for invasive evaluation and management of this special population in the CCL.

All authors: Cezar A. Iliescu MD, FSCAI; Cindy L. Grines MD, MSCAI; Joerg Herrmann, MD; Eric H. Yang MD; Mehmet Cilingiroglu, MD, FSCAI; Konstantinos Charitakis MD, FSCAI; Abdul Hakeem, MD, FSCAI; Konstantinos P. Toutouzas MD; Massoud A. Leesar, MD, and Konstantinos Marmagkiolis MD, FSCAI.

Other Guidance Documents

Evidence-based recommendations that promote optimal patient care based on current state-of-the-art science in interventional cardiology. 

Integrated Search Topics